Received Jul 2, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 1 | — | — |
What Do We Do With An Interrupted Dosing Schedule. Patient Received First Dose More Than 2 Months Ago ?; Initial report received on 17-Jun-2025. A nurse reported that a 64-year-old if male (race, race, ethnicity not reported) received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization but did not receive the second dose. No medical history or concomitant medication were reported. On an unknown date, the patient received dose 1 of a hepatitis B vaccine [HEPLISAV-B (lot #, expiration date, NDC #, route, and site not available)]. At the time of the report, the patient had not received the second dose yet. No additional information was reported. Reporter declined to provide further information. Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.